Share this:
Two Israeli firms have formed a cannabis-focused accelerator to support development of leading-edge initiatives in the burgeoning medical cannabis industry. “We see big opportunities in developing all kinds of new technologies and applications for both medical marijuana and hemp-based health products,” said Yossi Bornstein, Chairman and CEO of Shizim, a Tel Aviv-based biomed holding group.
Shizim has partnered with Seach, the operator of an Israeli cannabis farm, to offer a wide range of services backing entrepreneurs in the development of everything from new medical marijuana and hemp strains to processing and drug delivery technologies.